Literature DB >> 22069243

Impact of exclusive enteral nutrition on body composition and circulating micronutrients in plasma and erythrocytes of children with active Crohn's disease.

Konstantinos Gerasimidis1, Dinesh Talwar, Andrew Duncan, Pamela Moyes, Elaine Buchanan, Kamal Hassan, Denis O'Reilly, Paraic McGrogan, Christine Ann Edwards.   

Abstract

BACKGROUND: Nutritional therapy is the primary treatment for active pediatric Crohn's disease (CD) in the UK/Europe, improving disease activity and anthropometry. This study assessed changes in micronutrient status during exclusive enteral nutrition (EEN).
METHODS: Seventeen children (male/female: 8/9; median age: 12.7 years) with active CD were treated exclusively for 6-8 weeks on a polymeric feed (Modulen IBD; Nestle, UK). Body impedance was measured at baseline, during EEN, and posttreatment on normal diet and converted to z-scores of fat and lean mass. Blood samples for nutrient analysis were collected from 13 children at baseline, end of EEN, and posttreatment.
RESULTS: Lean but not fat mass improved at the end of EEN (initiation vs. end of EEN; fat mass [z-score]: -0.5 vs. -0.3; P = 0.141; lean mass [z-score]: -2.1 vs. -0.8; P < 0.0001). At baseline several children presented with suboptimal concentrations of carotenoids, trace elements, vitamin C, B6, and folate in plasma but not in erythrocytes. EEN improved concentrations for several nutrients, but more than 90% of patients had depleted concentrations of all carotenoids. The latter improved on normal diet but other micronutrients, which improved during EEN, returned toward pretreatment concentrations.
CONCLUSIONS: Lean but not fat mass improved at the end of EEN. Median concentrations for several plasma micronutrients improved on EEN but carotenoids were depleted. These findings may have implications for clinical practice and producers of enteral feeds. As plasma concentrations for many micronutrients can be affected by the acute phase response, measurements in erythrocytes may be a better marker of actual body stores.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22069243     DOI: 10.1002/ibd.21916

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  23 in total

1.  Anti-inflammatory effect by exclusive enteral nutrition (EEN) in a patient with juvenile idiopathic arthritis (JIA): brief report.

Authors:  Lillemor Berntson
Journal:  Clin Rheumatol       Date:  2014-05-23       Impact factor: 2.980

Review 2.  Exclusive enteral nutrition in children with Crohn's disease.

Authors:  Andrew S Day; Robert N Lopez
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

3.  Conceptual Model of Lean Body Mass in Pediatric Inflammatory Bowel Disease.

Authors:  Margaux J Barnes; Mary K Lynch; Molly D Lisenby; Traci Jester; Jeanine Maclin; Taylor Knight; Gordon Fisher; Barbara Gower
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-03       Impact factor: 2.839

4.  Impact of enteral nutrition on energy metabolism in patients with Crohn's disease.

Authors:  Jie Zhao; Jian-Ning Dong; Jian-Feng Gong; Hong-Gang Wang; Yi Li; Liang Zhang; Lu-Gen Zuo; Yun Feng; Li-Li Gu; Ning Li; Jie-Shou Li; Wei-Ming Zhu
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

Review 5.  Diet therapy for inflammatory bowel diseases: The established and the new.

Authors:  Franziska Durchschein; Wolfgang Petritsch; Heinz F Hammer
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

6.  Nutritional perspectives of children with Crohn's disease: a single-centre cohort observation of disease activity, energy expenditure and dietary intake.

Authors:  A E Wiskin; R Haggarty; N A Afzal; A Batra; S A Wootton; R M Beattie
Journal:  Eur J Clin Nutr       Date:  2016-06-22       Impact factor: 4.016

Review 7.  Growth Delay in Inflammatory Bowel Diseases: Significance, Causes, and Management.

Authors:  Kerry Wong; Daniela Migliarese Isaac; Eytan Wine
Journal:  Dig Dis Sci       Date:  2021-01-12       Impact factor: 3.199

8.  Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease.

Authors:  Ivana Copova; Ondrej Hradsky; Kristyna Zarubova; Lucie Gonsorcikova; Kristyna Potuznikova; Tereza Lerchova; Jiri Nevoral; Jiri Bronsky
Journal:  Eur J Pediatr       Date:  2018-08-20       Impact factor: 3.183

9.  Nutritional Therapy in Very Early-Onset Inflammatory Bowel Disease: A Case Report.

Authors:  Talya L Miller; Dale Lee; Mathew Giefer; Ghassan Wahbeh; David L Suskind
Journal:  Dig Dis Sci       Date:  2017-05-27       Impact factor: 3.199

10.  Time to Relapse in Children with Crohn's Disease Treated with Azathioprine and Nutritional Therapy or Corticosteroids.

Authors:  Ondrej Hradsky; Ivana Copova; Kristyna Zarubova; Jiri Nevoral; Jiri Bronsky
Journal:  Dig Dis Sci       Date:  2016-03-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.